Gut microbiota dysbiosis in patients with non-alcoholic fatty liver disease (Q46318841)

21 December 2017

title

Gut microbiota dysbiosis in patients with non-alcoholic fatty liver disease (English)

1 reference

21 December 2017

non-alcoholic fatty liver

main subject

1 reference

metabolic dysfunction–associated steatotic liver disease

inferred from title

1 reference

1 reference

Feng Shen

1

1 reference

21 December 2017

Rui-Dan Zheng

2

1 reference

21 December 2017

Xing-Qiang Sun

3

1 reference

21 December 2017

Wen-Jin Ding

4

1 reference

21 December 2017

Xiao-Ying Wang

5

1 reference

21 December 2017

Jian-Gao Fan

6

1 reference

21 December 2017

language of work or name

1 reference

1 August 2017

1 reference

21 December 2017

Hepatobiliary & Pancreatic Diseases International

published in

1 reference

21 December 2017

volume

16

1 reference

21 December 2017

issue

4

1 reference

21 December 2017

page(s)

375-381

1 reference

21 December 2017

The global NAFLD epidemic

cites work

1 reference

https://api.crossref.org/works/10.1016/S1499-3872(17)60019-5

7 January 2021

Gut microbiota and non-alcoholic fatty liver disease: new insights

1 reference

https://api.crossref.org/works/10.1016/S1499-3872(17)60019-5

7 January 2021

Role of gut microbiota: obesity and NAFLD.

1 reference

https://api.crossref.org/works/10.1016/S1499-3872(17)60019-5

7 January 2021

Gut–liver axis: The impact of gut microbiota on non alcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1016/S1499-3872(17)60019-5

7 January 2021

Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease.

1 reference

https://api.crossref.org/works/10.1016/S1499-3872(17)60019-5

7 January 2021

Elevated endotoxin levels in non-alcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1016/S1499-3872(17)60019-5

7 January 2021

Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH.

1 reference

https://api.crossref.org/works/10.1016/S1499-3872(17)60019-5

7 January 2021

t10,c12 conjugated linoleic acid upregulates hepatic de novo lipogenesis and triglyceride synthesis via mTOR pathway activation.

1 reference

https://api.crossref.org/works/10.1016/S1499-3872(17)60019-5

7 January 2021

Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice

1 reference

https://api.crossref.org/works/10.1016/S1499-3872(17)60019-5

7 January 2021

Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5

1 reference

https://api.crossref.org/works/10.1016/S1499-3872(17)60019-5

7 January 2021

Dysbiosis contributes to fibrogenesis in the course of chronic liver injury in mice

1 reference

https://api.crossref.org/works/10.1016/S1499-3872(17)60019-5

7 January 2021

Richness of human gut microbiome correlates with metabolic markers

1 reference

https://api.crossref.org/works/10.1016/S1499-3872(17)60019-5

7 January 2021

Guidelines for the diagnosis and management of nonalcoholic fatty liver disease: update 2010: (published in Chinese on Chinese Journal of Hepatology 2010; 18:163-166)

1 reference

https://api.crossref.org/works/10.1016/S1499-3872(17)60019-5

7 January 2021

Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1016/S1499-3872(17)60019-5

7 January 2021

Non-invasive assessment of hepatic steatosis in patients with NAFLD using controlled attenuation parameter and 1H-MR spectroscopy

1 reference

https://api.crossref.org/works/10.1016/S1499-3872(17)60019-5

7 January 2021

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1016/S1499-3872(17)60019-5

7 January 2021

Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities

1 reference

https://api.crossref.org/works/10.1016/S1499-3872(17)60019-5

7 January 2021

NAST: a multiple sequence alignment server for comparative analysis of 16S rRNA genes

1 reference

https://api.crossref.org/works/10.1016/S1499-3872(17)60019-5

7 January 2021

Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy

1 reference

https://api.crossref.org/works/10.1016/S1499-3872(17)60019-5

7 January 2021

QIIME allows analysis of high-throughput community sequencing data

1 reference

https://api.crossref.org/works/10.1016/S1499-3872(17)60019-5

7 January 2021

Statistical methods for detecting differentially abundant features in clinical metagenomic samples

1 reference

https://api.crossref.org/works/10.1016/S1499-3872(17)60019-5

7 January 2021

Dysbiosis gut microbiota associated with inflammation and impaired mucosal immune function in intestine of humans with non-alcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1016/S1499-3872(17)60019-5

7 January 2021

Recent advances in understanding enteric pathogenic Escherichia coli.

1 reference

https://api.crossref.org/works/10.1016/S1499-3872(17)60019-5

7 January 2021

Comparative genome analysis of Prevotella ruminicola and Prevotella bryantii: insights into their environmental niche.

1 reference

https://api.crossref.org/works/10.1016/S1499-3872(17)60019-5

7 January 2021

Gut microbiome and nonalcoholic fatty liver diseases

1 reference

https://api.crossref.org/works/10.1016/S1499-3872(17)60019-5

7 January 2021

Gut Microbiota of Nonalcoholic Fatty Liver Disease

1 reference

https://api.crossref.org/works/10.1016/S1499-3872(17)60019-5

7 January 2021

The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota

1 reference

https://api.crossref.org/works/10.1016/S1499-3872(17)60019-5

7 January 2021

https://api.crossref.org/works/10.1016/S1499-3872(17)60019-5

1 reference

7 January 2021

Ethanol and liver: recent insights into the mechanisms of ethanol-induced fatty liver

1 reference

https://api.crossref.org/works/10.1016/S1499-3872(17)60019-5

7 January 2021

Intestinal colonization by a Lachnospiraceae bacterium contributes to the development of diabetes in obese mice

1 reference

https://api.crossref.org/works/10.1016/S1499-3872(17)60019-5

7 January 2021

Colonic inflammation accompanies an increase of β-catenin signaling and Lachnospiraceae/Streptococcaceae bacteria in the hind gut of high-fat diet-fed mice

1 reference

https://api.crossref.org/works/10.1016/S1499-3872(17)60019-5

7 January 2021

A phylo-functional core of gut microbiota in healthy young Chinese cohorts across lifestyles, geography and ethnicities

1 reference

https://api.crossref.org/works/10.1016/S1499-3872(17)60019-5

7 January 2021

Restoration of the gut microbial habitat as a disease therapy

1 reference

https://api.crossref.org/works/10.1016/S1499-3872(17)60019-5

7 January 2021

10.1016/S1499-3872(17)60019-5

Identifiers

DOI

1 reference

21 December 2017

1 reference

21 December 2017